Status:
TERMINATED
BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort
Lead Sponsor:
Women's College Hospital
Collaborating Sponsors:
McGill University Health Centre/Research Institute of the McGill University Health Centre
University of British Columbia
Conditions:
Atopic Dermatitis
Skin Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atopic dermatitis (eczema) is a complicated skin condition. In fact, it represents many different underlying problems. These include abnormalities in the skin barrier, the immune system and the abilit...
Eligibility Criteria
Inclusion
- Atopic dermatitis according to the Hanifin and Rajka criteria.
- Validated Investigator Global Assessment score of 3 or 4 out of 4
- Eczema Area and Severity Index (EASI) score ≥7.1
- Moderate to severe disease as above despite an adequate trial of topical therapy.
Exclusion
- Treatment with phototherapy or oral systemic immune-modulating agents (cyclosporine, methotrexate, azathioprine, mycophenolate) less than 30 days before baseline.
- Treatment with systemic biologic (dupilumab) or experimental therapeutic less than 90 days before baseline.
- Current treatment with oral or intramuscular corticosteroids within 30 days prior to baseline. Topical, intralesional or inhaled corticosteroids are allowed.
- Participating in a clinical trial assessing an investigational agent for atopic dermatitis (topical, systemic or device) within 90 days prior to enrollment.
Key Trial Info
Start Date :
September 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2025
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04818138
Start Date
September 27 2021
End Date
June 5 2025
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's College Hospital
Toronto, Ontario, Canada, M5S 1B2